The arrival of amivantamab offers a important advance for individuals battling cancers with c-MET aberration. This novel antibody, a precise agent of multiple MET kinase plus human epidermal growth factor receptor 2 https://nikolasyvxl127710.wikitelevisions.com/9394952/amivantamab_a_potential_solution_for_c_met_associated_tumors